• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2型糖尿病中的SIRT1:作用机制与治疗潜力

SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential.

作者信息

Kitada Munehiro, Koya Daisuke

机构信息

Division of Diabetology and Endocrinology, Kanazawa Medical University, Kahoku, Japan.

出版信息

Diabetes Metab J. 2013 Oct;37(5):315-25. doi: 10.4093/dmj.2013.37.5.315.

DOI:10.4093/dmj.2013.37.5.315
PMID:24199159
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3816131/
Abstract

The prevalence of type 2 diabetes mellitus (T2DM) has been increasing worldwide. Therefore, a novel therapeutic strategy by which to prevent T2DM is urgently required. Calorie restriction (CR) can retard the aging processes, and delay the onset of numerous age-related diseases including diabetes. Metabolic CR mimetics may be therefore included as novel therapeutic targets for T2DM. Sirtuin 1 (SIRT1), a NAD(+)-dependent histone deacetylase that is induced by CR, is closely associated with lifespan elongation under CR. SIRT1 regulates glucose/lipid metabolism through its deacetylase activity on many substrates. SIRT1 in pancreatic β-cells positively regulates insulin secretion and protects cells from oxidative stress and inflammation, and has positive roles in the metabolic pathway via the modulation in insulin signaling. SIRT1 also regulates adiponectin secretion, inflammation, glucose production, oxidative stress, mitochondrial function, and circadian rhythms. Several SIRT1 activators, including resveratrol have been demonstrated to have beneficial effects on glucose homeostasis and insulin sensitivity in animal models of insulin resistance. Therefore, SIRT1 may be a novel therapeutic target for the prevention of T2DM, implicating with CR. In this review, we summarize current understanding of the biological functions of SIRT1 and discuss its potential as a promising therapeutic target for T2DM.

摘要

2型糖尿病(T2DM)在全球的患病率一直在上升。因此,迫切需要一种预防T2DM的新型治疗策略。热量限制(CR)可以延缓衰老过程,并延迟包括糖尿病在内的许多与年龄相关疾病的发病。因此,代谢性CR模拟物可能成为T2DM的新型治疗靶点。沉默调节蛋白1(SIRT1)是一种由CR诱导的NAD(+)依赖性组蛋白脱乙酰酶,与CR条件下的寿命延长密切相关。SIRT1通过其对许多底物的脱乙酰酶活性调节葡萄糖/脂质代谢。胰腺β细胞中的SIRT1正向调节胰岛素分泌,并保护细胞免受氧化应激和炎症的影响,且通过调节胰岛素信号在代谢途径中发挥积极作用。SIRT1还调节脂联素分泌、炎症、葡萄糖生成、氧化应激、线粒体功能和昼夜节律。包括白藜芦醇在内的几种SIRT1激活剂已被证明在胰岛素抵抗动物模型中对葡萄糖稳态和胰岛素敏感性具有有益作用。因此,SIRT1可能是预防T2DM的新型治疗靶点,与CR相关。在本综述中,我们总结了目前对SIRT1生物学功能的认识,并讨论了其作为T2DM有前景的治疗靶点的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cab/3816131/7eecca40059c/dmj-37-315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cab/3816131/7eecca40059c/dmj-37-315-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cab/3816131/7eecca40059c/dmj-37-315-g001.jpg

相似文献

1
SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential.2型糖尿病中的SIRT1:作用机制与治疗潜力
Diabetes Metab J. 2013 Oct;37(5):315-25. doi: 10.4093/dmj.2013.37.5.315.
2
Sirtuins as possible drug targets in type 2 diabetes.Sirtuins 可能成为 2 型糖尿病的药物靶点。
Curr Drug Targets. 2013 Jun 1;14(6):622-36. doi: 10.2174/1389450111314060002.
3
Sirtuins and Type 2 Diabetes: Role in Inflammation, Oxidative Stress, and Mitochondrial Function.沉默调节蛋白与2型糖尿病:在炎症、氧化应激和线粒体功能中的作用
Front Endocrinol (Lausanne). 2019 Mar 27;10:187. doi: 10.3389/fendo.2019.00187. eCollection 2019.
4
SIRT1: a promising therapeutic target in type 2 diabetes mellitus.SIRT1:2 型糖尿病治疗的一个有前途的靶点。
Arch Physiol Biochem. 2024 Feb;130(1):13-28. doi: 10.1080/13813455.2021.1956976. Epub 2021 Aug 11.
5
SIRT1 and insulin resistance.沉默调节蛋白1与胰岛素抵抗
Nat Rev Endocrinol. 2009 Jul;5(7):367-73. doi: 10.1038/nrendo.2009.101. Epub 2009 May 19.
6
Mitochondrial biogenesis: pharmacological approaches.线粒体生物合成:药理学方法。
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
7
Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo.SIRT1的小分子激活剂可在体内复制由卡路里限制引发的信号通路。
BMC Syst Biol. 2009 Mar 10;3:31. doi: 10.1186/1752-0509-3-31.
8
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes.作为治疗2型糖尿病的疗法的SIRT1小分子激活剂。
Nature. 2007 Nov 29;450(7170):712-6. doi: 10.1038/nature06261.
9
Resveratrol attenuates type 2 diabetes mellitus by mediating mitochondrial biogenesis and lipid metabolism via Sirtuin type 1.白藜芦醇通过沉默调节蛋白1介导线粒体生物合成和脂质代谢来减轻2型糖尿病。
Exp Ther Med. 2018 Jan;15(1):576-584. doi: 10.3892/etm.2017.5400. Epub 2017 Oct 30.
10
SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications.SIRT1,一种模拟热量限制的物质,用于治疗2型糖尿病和糖尿病血管并发症的新方法。
Endocr Metab Immune Disord Drug Targets. 2010 Mar;10(1):16-24. doi: 10.2174/187153010790827957.

引用本文的文献

1
High-intensity interval training (HIIT) ameliorates cardiac hypertrophy and fibrosis in diabetic rats: the role of P53 and SIRT1.高强度间歇训练(HIIT)改善糖尿病大鼠的心脏肥大和纤维化:P53和SIRT1的作用。
J Mol Histol. 2025 Sep 8;56(5):305. doi: 10.1007/s10735-025-10596-z.
2
Patterns of transcriptomic aging in the hippocampus of rhesus macaques highlight midlife transitions.恒河猴海马体中转录组衰老模式凸显中年转变。
Geroscience. 2025 Aug 18. doi: 10.1007/s11357-025-01834-z.
3
Distachionate and Its Nanocomposites Modulate Oxidative Stress, Inflammation, and Diabetes-Related Genes in High-Fructose/Streptozotocin Model.

本文引用的文献

1
Evidence for a common mechanism of SIRT1 regulation by allosteric activators.所有别构激活剂调控 SIRT1 的共同机制的证据。
Science. 2013 Mar 8;339(6124):1216-9. doi: 10.1126/science.1231097.
2
Sirtuins as possible drug targets in type 2 diabetes.Sirtuins 可能成为 2 型糖尿病的药物靶点。
Curr Drug Targets. 2013 Jun 1;14(6):622-36. doi: 10.2174/1389450111314060002.
3
High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition.
双去氢青蒿素及其纳米复合材料对高果糖/链脲佐菌素模型中氧化应激、炎症及糖尿病相关基因的调控作用
ACS Omega. 2025 Jul 23;10(30):33353-33370. doi: 10.1021/acsomega.5c03465. eCollection 2025 Aug 5.
4
Molecular Variants in Gene Among Saudi Women Diagnosed with Gestational Diabetes Mellitus: A Case-Control Study.沙特被诊断为妊娠期糖尿病的女性中基因的分子变异:一项病例对照研究。
Int J Womens Health. 2025 Jul 28;17:2335-2352. doi: 10.2147/IJWH.S510344. eCollection 2025.
5
Harnessing animal model and computational experiments to discover antidiabetic compounds in Ficus racemosa.利用动物模型和计算实验发现聚果榕中的抗糖尿病化合物。
BMC Complement Med Ther. 2025 Jul 2;25(1):215. doi: 10.1186/s12906-025-04845-7.
6
Capsaicin counteracts dexamethasone-induced osteoporosis and metabolic disturbances in rats: role of AMPK/SIRT1/β-catenin/RUNX2 pathway.辣椒素可对抗地塞米松诱导的大鼠骨质疏松和代谢紊乱:AMPK/SIRT1/β-连环蛋白/RUNX2信号通路的作用
J Mol Histol. 2025 May 28;56(3):175. doi: 10.1007/s10735-025-10460-0.
7
Role of Diabetes and its metabolic pathways in Epilepsy: An insight to various target approaches.糖尿病及其代谢途径在癫痫中的作用:对各种靶向方法的见解
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 10. doi: 10.1007/s00210-025-04245-1.
8
Biochanin‑A as SIRT‑1 modulator in preventing statin‑associated diabetogenesis: An study.作为SIRT-1调节剂的染料木黄酮预防他汀类药物相关性糖尿病发生的研究
Biomed Rep. 2025 Mar 24;22(5):91. doi: 10.3892/br.2025.1969. eCollection 2025 May.
9
SIRT1 Attenuates Neuropathic Pain via CDK5-Kalirin-7 Signaling Pathway in Type 2 Diabetic Rats.SIRT1通过CDK5-Kalirin-7信号通路减轻2型糖尿病大鼠的神经性疼痛。
Mol Neurobiol. 2025 Mar 25. doi: 10.1007/s12035-025-04843-3.
10
Harnessing the FOXO-SIRT1 axis: insights into cellular stress, metabolism, and aging.利用FOXO-SIRT1轴:对细胞应激、代谢和衰老的见解。
Biogerontology. 2025 Feb 26;26(2):65. doi: 10.1007/s10522-025-10207-0.
肥胖男性大剂量白藜芦醇补充:一项基于代谢底物、胰岛素敏感性和身体成分的研究者发起、随机、安慰剂对照临床试验。
Diabetes. 2013 Apr;62(4):1186-95. doi: 10.2337/db12-0975. Epub 2012 Nov 28.
4
Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance.白藜芦醇补充剂不能改善糖耐量正常的非肥胖女性的代谢功能。
Cell Metab. 2012 Nov 7;16(5):658-64. doi: 10.1016/j.cmet.2012.09.015. Epub 2012 Oct 25.
5
Sirtuins and renal diseases: relationship with aging and diabetic nephropathy.沉默调节蛋白与肾脏疾病:与衰老和糖尿病肾病的关系。
Clin Sci (Lond). 2013 Feb;124(3):153-64. doi: 10.1042/CS20120190.
6
SIRT1 inactivation induces inflammation through the dysregulation of autophagy in human THP-1 cells.SIRT1 失活通过人 THP-1 细胞自噬失调诱导炎症。
Biochem Biophys Res Commun. 2012 Oct 12;427(1):191-6. doi: 10.1016/j.bbrc.2012.09.042. Epub 2012 Sep 17.
7
Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ.SIRT1 通过去乙酰化 Pparγ 介导白色脂肪组织的棕色样重塑。
Cell. 2012 Aug 3;150(3):620-32. doi: 10.1016/j.cell.2012.06.027.
8
SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function.SIRT1 对于 AMPK 的激活以及白藜芦醇对线粒体功能的有益作用是必需的。
Cell Metab. 2012 May 2;15(5):675-90. doi: 10.1016/j.cmet.2012.04.003.
9
Angiogenic deficiency and adipose tissue dysfunction are associated with macrophage malfunction in SIRT1-/- mice.SIRT1-/- 小鼠中血管生成缺陷和脂肪组织功能障碍与巨噬细胞功能障碍有关。
Endocrinology. 2012 Apr;153(4):1706-16. doi: 10.1210/en.2011-1667. Epub 2012 Feb 7.
10
Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.白藜芦醇通过抑制 cAMP 磷酸二酯酶改善与衰老相关的代谢表型。
Cell. 2012 Feb 3;148(3):421-33. doi: 10.1016/j.cell.2012.01.017.